Cargando…

Tumour markers of prognosis in colorectal cancer

Detalles Bibliográficos
Autores principales:	McLeod, H L, Murray, G I
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1999
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362193/ https://www.ncbi.nlm.nih.gov/pubmed/9888457 http://dx.doi.org/10.1038/sj.bjc.6690033

Ejemplares similares

Characterization of dihydropyrimidine dehydrogenase in human colorectal tumours.
por: McLeod, H. L., et al.
Publicado: (1998)

Unfavourable expression of pharmacologic markers in mucinous colorectal cancer
por: Glasgow, S C, et al.
Publicado: (2005)

Cell Surface Markers in Colorectal Cancer Prognosis
por: Belov, Larissa, et al.
Publicado: (2010)

Microbial markers in colorectal cancer detection and/or prognosis
por: Villéger, Romain, et al.
Publicado: (2018)

Case of Medullary Tumour of the Arm, &c.
por: McLeod, Kenneth
Publicado: (1867)

Comparative genomic hybridization and chromosomal instability in solid tumours
por: Rooney, P H, et al.
Publicado: (1999)

c-erbB-2 is not a major factor in the development of colorectal cancer
por: McKay, J A, et al.
Publicado: (2002)

International scientific communications in the field of colorectal tumour markers
por: Ivanov, Krasimir, et al.
Publicado: (2017)

Colorectal cancer genomics: evidence for multiple genotypes which influence survival
por: Rooney, P H, et al.
Publicado: (2001)

Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis
por: Mei, Z, et al.
Publicado: (2014)

Comment on ‘Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis'
por: Park, J H, et al.
Publicado: (2014)

The association of preoperative serum tumour markers with Dukes' stage and survival in colorectal cancer.
por: Lindmark, G., et al.
Publicado: (1995)

Tumour-marker levels and prognosis in malignant teratoma of the testis.
por: Germa-Lluch, J. R., et al.
Publicado: (1980)

Inflammatory Markers and MicroRNAs: The Backstage Actors Influencing Prognosis in Colorectal Cancer Patients
por: Nasr, Rihab, et al.
Publicado: (2018)

Podocalyxin is a marker of poor prognosis in colorectal cancer
por: Kaprio, Tuomas, et al.
Publicado: (2014)

RNA profiling of cyclooxygenases 1 and 2 in colorectal cancer
por: Church, R D, et al.
Publicado: (2004)

Beclin 1 over- and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia
por: Koukourakis, M I, et al.
Publicado: (2010)

Role of tumour markers in monitoring epithelial ovarian cancer
por: Meyer, T, et al.
Publicado: (2000)

Cancer pharmacogenetics
por: Marsh, S, et al.
Publicado: (2004)

Therapeutic Targeting of the Tumour Microenvironment in Metastatic Colorectal Cancer
por: Dmello, Rhynelle S., et al.
Publicado: (2021)

Circulating tumour DNA in colorectal cancer management
por: Cohen, Ryan, et al.
Publicado: (2023)

The Value of Haematological Parameters and Tumour Markers in the Prediction of Intestinal Obstruction in 1474 Chinese Colorectal Cancer Patients
por: Cao, Yinghao, et al.
Publicado: (2020)

Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis
por: Jubb, Adrian M, et al.
Publicado: (2010)

Clinical significance of circulating tumour cells and tumour marker detection in the chemotherapeutic evaluation of advanced colorectal cancer
por: Shen, Feifei, et al.
Publicado: (2021)

Relationship between immune checkpoint proteins, tumour microenvironment characteristics, and prognosis in primary operable colorectal cancer
por: Al‐Badran, Sara SF, et al.
Publicado: (2020)

Tumour markers in breast cancer.
por: Cove, D. H., et al.
Publicado: (1979)

Abnormal expression of TRIB3 in colorectal cancer: a novel marker for prognosis
por: Miyoshi, N, et al.
Publicado: (2009)

Comparison of four serum tumour markers in the diagnosis of colorectal carcinoma.
por: van der Schouw, Y. T., et al.
Publicado: (1992)

CYP3A4 and VDR gene polymorphisms and the risk of prostate cancer in men with benign prostate hyperplasia
por: Tayeb, M T, et al.
Publicado: (2003)

Molecular markers of prognosis in canine cortisol‐secreting adrenocortical tumours
por: Sanders, Karin, et al.
Publicado: (2019)

Bone Tumours. Diagnosis, Treatment and Prognosis
por: Dodge, O. G.
Publicado: (1979)

Molecular markers in circulating tumour cells from metastatic colorectal cancer patients
por: Gazzaniga, Paola, et al.
Publicado: (2010)

Combined epithelial marker analysis of tumour budding in stage II colorectal cancer
por: Slik, Khadija, et al.
Publicado: (2018)

Serum proteins as tumour markers for breast cancer.
por: Mattison, P., et al.
Publicado: (1981)

Response to comment on ‘Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis'
por: Mei, Z, et al.
Publicado: (2014)

Transforming growth factor beta 1 expression in human colorectal tumours: an independent prognostic marker in a subgroup of poor prognosis patients.
por: Robson, H., et al.
Publicado: (1996)

Patients with mesenchymal tumours and high Fusobacteriales prevalence have worse prognosis in colorectal cancer (CRC)
por: Salvucci, Manuela, et al.
Publicado: (2022)

Circulating tumour-derived nucleic acids in cancer patients: potential applications as tumour markers
por: Chan, K C A, et al.
Publicado: (2007)

Tumour heterogeneity and evolutionary dynamics in colorectal cancer
por: Chan, Dedrick Kok Hong, et al.
Publicado: (2021)

The in situ local immune response, tumour senescence and proliferation in colorectal cancer
por: Roxburgh, C S, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1hbkg0dm0eljmh0hghhf10o6g8